Hong, D. S., Sen, S., Schweizer, C., Sanders, A., Grimes, C., Pericle, F., Gagliardi, C., Barlow, J., Salameh, A., Curran, M. A. (2025). A phase 1a/1b study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of IMGS-001 in patients with relapsed or refractory advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2686